Revefenacin Impurity 22 | CAS 171723-80-1 - Request Quote
Revefenacin Impurity 22
| SZ CAT No: | SZ-R043028 |
| CAS No | 171723-80-1 |
| Mol.F. | C25H26N2O2 |
| Mol.Wt. | 386.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Revefenacin Impurity 22 is chemically 1-Benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate. Revefenacin Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Revefenacin Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Revefenacin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 171723-80-1
Purchase 171723-80-1
Order 171723-80-1
Enquire 171723-80-1
price of 171723-80-1
171723-80-1 Supplier
171723-80-1 Manufacturer
171723-80-1 Exporter
buy high quality Revefenacin Impurity 22
Purchase Revefenacin Impurity 22
Revefenacin Impurity 22 suppliers
Revefenacin Impurity 22 manufacturers
Revefenacin Impurity 22 price
Order Revefenacin Impurity 22
Enquire Revefenacin Impurity 22
Revefenacin Impurity 22 cost
Revefenacin Impurity 22 Supplier
Revefenacin Impurity 22 Distributor
Revefenacin Impurity 22 for Method Validation
Revefenacin Reference Standard
Revefenacin Impurity 22 for ANDA Filing
Revefenacin Impurity 22 for Forced Degradation Studies
Revefenacin Impurity 22 Identification Standards
Revefenacin Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


